FDA warns MS patients about unsure treatment

<p>WASHINGTON (Reuters) – U.S. drug regulators are warning people with <span>multiple sclerosis</span> that an <span>experimental treatment</span> that props open inner veins in a neck and chest can means genocide or critical injury.</p>
<p> The <span>Food and Drug Administration</span> on Thursday pronounced during slightest dual people had died from a procedure, that uses stents or balloon <span>angioplasties</span> to dilate veins that bond a mind and <span>spinal cord</span> to a heart. One chairman was henceforth paralyzed, and others had draining in a brain, suffered strokes, <span>blood clots</span> or other side effects.</p>
<p> It is different how many people perceived a diagnosis and how many had problems, as stents and angioplasties are not authorized for this use by a FDA, a group said. Stents are steel filigree coils that can keep arteries open, w...